Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Bayer | OphthalmologyBayer | Ophthalmology
VS
Alembic Pharmaceuticals LimitedAlembic Pharmaceuticals Limited
Bayer | Ophthalmology

Bayer | Ophthalmology

Basel, CH

Last Update: 01/05/2026

View Profile
759/1000Fair

Retinal disease represents a major global health burden, especially as the world population ages and grows. Experts estimate that today at least one billion people live with vision impairment that could have been prevented or has yet to be addressed. Social Media Pri...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:12
12-month incidents
0
Known data breaches
0
Attack type number
0
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Alembic Road, Vadodara, 390003, IN

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.alembic-india.com
757/1000Fair

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is t...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,168
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Bayer | Ophthalmology

Bayer | Ophthalmology

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Bayer | Ophthalmology in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Alembic Pharmaceuticals Limited in 2026.

Incidents

Incident History - Bayer | Ophthalmology (X = Date, Y = Severity)

Bayer | Ophthalmology cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Alembic Pharmaceuticals Limited (X = Date, Y = Severity)

Alembic Pharmaceuticals Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Bayer | Ophthalmology

Bayer | Ophthalmology

Incidents
No explicit notable incidents reported.
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Incidents
No explicit notable incidents reported.

FAQ

Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one has the best AI Cybersecurity Score ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one has experienced more cyber incidents in the past ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one has experienced more cyber incidents this year ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one has experienced at least one ransomware attack ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one has experienced at least one data breach ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one has experienced at least one targeted cyberattack ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one has experienced at least one vulnerability ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one holds the most compliance certifications ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one holds the fewest compliance certifications ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one has the most subsidiaries ?
Between Bayer | Ophthalmology company and Alembic Pharmaceuticals Limited company, which one has the largest number of employees ?
Between Bayer | Ophthalmology and Alembic Pharmaceuticals Limited, which company holds both SOC 2 Type 1 certifications ?
Between Bayer | Ophthalmology and Alembic Pharmaceuticals Limited, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Bayer | Ophthalmology or Alembic Pharmaceuticals Limited ?
Which company is PCI DSS compliant - Bayer | Ophthalmology or Alembic Pharmaceuticals Limited ?
Between Bayer | Ophthalmology and Alembic Pharmaceuticals Limited, which company complies with HIPAA regulations for healthcare data ?
Between Bayer | Ophthalmology and Alembic Pharmaceuticals Limited, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-56078
SUMMARY

PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-56077
SUMMARY

PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-56076
SUMMARY

PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-56075
SUMMARY

PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-56074
SUMMARY

PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 5.5)
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
CVSS4
Base Score: 6.8
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
1.8